Oxidative modification of high-density lipoprotein 3 induced by human polymorphonuclear neutrophils: Protective effect of pentoxifylline

European Journal of Biochemistry

Volumn 259, Issue 1-2, 1999, Pages 32-39

  Cogny, Anne ^a   Paul, Jean Louis ^a,b   Surbled, Béatrice ^a   Atger, Véronique ^a   Lenoble, Michèle ^c   Moatti, Nicole ^a,b  

^a HÔPITAL BROUSSAIS   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c Laboratoires Hoechst   (France)

Author keywords

tocopherol; HDL; Neutrophils; Pentoxifylline; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; APOLIPOPROTEIN A1; FORMYLMETHIONYLLEUCYLPHENYLALANINE; HIGH DENSITY LIPOPROTEIN; IRON CHELATE; NITRILOTRIACETATE IRON; OXYGEN RADICAL; PENTOXIFYLLINE; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATE; SODIUM CHLORIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; XANTHINE; XANTHINE OXIDASE;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LIPID PEROXIDATION; LIPOPROTEIN METABOLISM; NEUTROPHIL; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

ANTIOXIDANTS; APOLIPOPROTEIN A-I; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, HDL3; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; OXIDATION-REDUCTION; PENTOXIFYLLINE; RESPIRATORY BURST; TETRADECANOYLPHORBOL ACETATE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VITAMIN E;

EID: 0033555733     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1999.00002.x     Document Type: Article

References (49)

1. Gordon, D. & Rifkind, B.M. (1989) High-density lipoproteins: the clinical implications of recent studies. N. Engl. J. Med. 321, 1311-1315.
2. Pieters, M.N., Schouten, D. & Van Berkel, T.J. (1994) In vitro and in vivo evidence for the role of HDL in reverse cholesterol transport. Biochim. Biophys. Acta 1225, 125-134.
3. Rifici, V.A. & Khachadurian, A.K. (1996) Oxidation of high density lipoproteins: characterization and effects on cholesterol efflux from J774 macrophages. Biochim. Biophys. Acta 1299, 87-94.
4. Bonnefont-Rousselot, D., Motta, C., Khalil, A.O., Sola, R., La Ville, A.E., Delattre, J. & Gardès-Albert, M. (1995) Physicochemical changes in human high-density lipoproteins (HDL) oxidized by gamma radiolysis-generated oxyradicals. Effect on their cholesterol effluxing capacity. Biochim. Biophys. Acta 1255, 23-30.
5. Morel, D. (1994) Reduced cholesterol efflux to mildly oxidized high density lipoprotein. Biochem. Biophys. Res. Commun. 200, 408-416.
6. Salmon, S., Mazière, C., Auclair, M., Theron, L., Santus, R. & Mazière, J.C. (1992) Malondialdehyde modification and copper-induced auto-oxidation of high-density lipoprotein decrease cholesterol efflux from human cultured fibroblasts. Biochim. Biophys. Acta 1125, 230-235.
7. Nagano, Y., Arai, H. & Kita, T. (1991) High-density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. Proc. Natl. Acad. Sci. 88, 6457-6461.
8. Musanti, R. & Ghiselli, G. (1993) Interaction of oxidized HDLs with J774-A1 macrophages causes intracellular accumulation of unesterified cholesterol. Arterioscler. Thromb. 13, 1334-1345.
9. La Ville, A.E., Sola, R., Balanya, J., Turner, P.R. & Masana, L. (1994) In vitro oxidised HDL is recognised by the scavenger receptor of macrophages: implications for its protective role in vivo. Atherosclerosis 105, 179-189.
10. Shoukry, M.I., Gong, E.L. & Nichols, A.V. (1994) Apolipoprotein-lipid association in oxidatively modified HDL and LDL. Biochim. Biophys. Acta 1210, 355-360.
11. Ghiselli, G., Giorgini, L., Gelati, M. & Musanti, R. (1992) Oxidatively modified HDLs are potent inhibitors of cholesterol biosynthesis in human skin fibroblasts. Arterioscler. Thromb. 12, 929-935.
12. 2+ mediated oxidation. FEBS Lett. 314, 199-202.
13. Parthasarathy, S., Barnett, J. & Fong, L.G. (1990) High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim. Biophys. Acta 1044, 275-283.
14. Salmon, S., Santus, R., Mazière, J.C., Aubailly, M. & Haigle, J. (1992) Modified apolipoprotein pattern after irradiation of human high-density lipoproteins by ultraviolet-B. Biochim. Biophys. Acta 1128, 167-173.
15. Kling, D., Holzschuh, T. & Betz, E. (1993) Recruitment and dynamics of leukocytes in the formation of arterial intimal thickening: a comparative study with normo- and hypercholesterolemic rabbits. Atherosclerosis 101, 79-96.
16. Prescott, M.F., McBride, K.C. & Court, M. (1989) Development of intimal lesions after leukocyte migration into the vascular wall. Am. J. Pathol. 135, 835-846.
17. Hagihara, H., Nomoto, A., Mutoh, A., Yamaguchi, I. & Ono, T. (1991) Role of inflammatory responses in initiation of atherosclerosis: effects of anti-inflammatory drags on cuff-induced leukocyte accumulation and intimal thickening of rabbit carotid artery. Atherosclerosis 91, 107-116.
18. Thomas, M.J., Shirley, P.S., Hedrick, C.C. & DeChatelet, L.R. (1986) Role of free radical processes in stimulated human polymorphonuclear leukocytes. Biochemistry 25, 8042-8048.
19. Cogny, A., Paul, J.L., Atger, V., Soni, T. & Moatti, N. (1994) Structural changes of high-density lipoprotein apolipoproteins following incubation with human polymorphonuclear cells. Eur. J. Biochem. 222, 965-973.
20. Cogny, A., Atger, V., Paul, J.L., Soni, T. & Moatti, N. (1996) High-density lipoprotein 3 physicochemical modifications induced by interaction with human polymorphonuclear leucocytes affect their ability to remove cholesterol from cells. Biochem. J. 314, 285-292.
21. Brieland, J.K. & Fantone, J.C. (1991) Ferrous iron release from transferrin by human neutrophil-derived superoxide anion: effect of pH and iron saturation. Arch. Biochem. Biophys. 284, 78-83.
22. Biemond, P., van Eijk, H.G., Swank, A.J.G. & Koster, J.F. (1984) Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes: possible mechanism in inflammation diseases. J. Clin. Invest. 73, 1576-1579.
23. Lamb, D.J., Mitchinson, M.J. & Leake, D.S. (1995) Transition metal ions within human atherosclerotic lesions can catalyse the oxidation of low density lipoprotein by macrophages. FEBS Lett. 374, 12-16.
24. Swain, J. & Gutteridge, J.M.C. (1995) Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material. FEBS Lett. 368, 513-515.
25. Smith, C., Mitchinson, M.J., Aruoma, O.I. & Halliwell, B. (1992) Stimulation of lipid peroxidation and hydroxyl-radical generation by contents of human atherosclerotic lesions. Biochem. J. 286, 901-905.
26. Gillings, D.B. (1995) Pentoxifylline and intermittent claudication: review of clinical trials and cost-effectiveness analyses. J. Cardiovasc. Pharmacol. 25, 544-550.
27. Currie, M.S., Murali, K., Rao, K., Padmanabhan, J., Jones, A., Crawford, J. & Cohen, H.J. (1990) Stimulus-specific effects of pentoxifylline on neutrophil CR3 expression, degranulation, and superoxide production. J. Leukocyte Biol. 47, 244-250.
28. Sourbier, P., Perianin, A. & Hakim, J. (1987) In vitro effect of pentoxifylline on human neutrophil function. In Pentoxifylline and Leucocyte Function (Mandell, G.L. & Novick, W.J., ed.), pp. 56-67. Hoechst-Roussel Pharm. Inc, FL, USA.
29. Boyum, A., Lovhaug, D., Tresi, L. & Nordlie, E.M. (1991) Separation of leucocytes: improved cell purity by fine adjustments of gradient medium density and osmolality. Scand. J. Immunol. 34, 697-712.
30. Johnston, R., Kell, B.B., Misro, H.P., Lehmeyer, J.E., Webbs, L.S., Baehme, R.L. & Rajacopalan, K.V. (1975) The role of superoxide anion generation in phagocytic bacterial activity. J. Clin. Invest. 55, 1357-1372.
31. van Gelder, B.F. & Slater, E.C. (1962) The extinction coefficient of cytochrome C. Biochim. Biophys. Acta 58, 593-595.
32. Bieri, J.G., Tolliver, T.J. & Gatignani, B.S. (1979) Simultaneous determination of alpha-tocopherol and retinol in plasma or red cells by high pressure-chromatography. Am. J. Clin. Nutr. 32, 2143-2149.
33. Richard, M.J., Portal, B., Meo, J., Coudray, C., Hadjian, A. & Favier, A. (1992) Malondialdehyde Kit evaluated for determining plasma and lipoprotein fractions that react with thiobarbituric acid. Clin. Chem. 38, 704-709.
34. Kamal-Eldin, A. & Appelqvist, L.A. (1996) The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids 31, 671-701.
35. .- with α-tocopherol in ethanol solutions. In Oxyradicals and Their Scavenger Systems (Cohen, C. & Greenwald, R., eds), pp. 26-30. Elsevier/North Holland, Amsterdam.
36. Kritharides, L., Jessup, W. & Dean, R.T. (1995) Macrophages require both iron and copper to oxidize low-density lipoprotein in Hanks' balanced salt solution. Arch. Biochem. Biophys. 323, 127-136.
37. Halliwell, B. & Gutteridge, J.M.C. (1984) Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. 219, 1-14.
38. Halliwell, B. & Gutteridge, J.M.C. (1985) The importance of free radicals and catalytic metal ions in human diseases. Mol. Aspects Med. 8, 89-193.
39. Ryan, T.P. & Aust., S.D. (1992) The role of iron in oxygen-mediated toxicities. Crit. Rev. Toxicol. 22, 119-141.
40. Ludwig, P.W., Hunninghake, D.B. & Hoidal, J.R. (1982) Increased leukocyte oxidative metabolism in hyperlipoproteinaemia. Lancet ii, 348-350.
41. Mohacsi, A., Kozlovszky, B., Kiss, I., Seres, I. & Fülöp, T. (1996) Neutrophils obtained from obliterative atherosclerotic patients exhibit enhanced resting respiratory burst and increased degranulation in response to various stimuli. Biochim. Biophys. Acta 1316, 210-216.
42. Slater, K., Wiseman, M.S., Shale, D.J. & Fletcher, J. (1987) The effect of pentoxifylline on neutrophil function in vitro and ex vivo in human volunteers. Pentoxifylline and Leucocyte Function (Mandell, G.L. & Novick, W.J., ed.), pp. 115-123. Hoechst-Roussel Pharm. Inc, FL, USA.
43. Crouch, S.P.M. & Fletcher, J. (1992) Effect of ingested pentoxifylline on neutrophil superoxide anion production. Infect. Immun. 60, 4504-4509.
44. McGarrity, S.T., Stephenson, A.H. & Webster, R.O. (1989) Regulation of human neutrophil functions by adenine nucleotides. J. Immunol. 6, 1986-1994.
45. Ciuffetti, G., Mercuri, M., Ott, C., Lombardini, R., Paltriccia, R., Lupattelli, G., Santambrogio, L. & Mannarino, E. (1991) Use of pentoxifylline as an inhibitor of free radical generation in peripheral vascular disease: results of a double-blind placebo-controlled study. Eur. J. Clin. Pharmacol. 41, 511-515.
46. Franzini, E., Sellak, H., Hakim, J. & Pasquier, C. (1993) Oxidative damage to lysozyme by the hydroxyl radical: comparative effects of scavengers. Biochim. Biophys. Acta 1203, 11-17.
47. Pasquier, C., Franzini, E., Abedinzadeh, Z., Kaouadji, M.N. & Hakim, J. (1991) Gamma and pulse radiolysis study of pentoxifylline, a methylxanthine. Int. J. Radiat. Biol. 60, 433-447.
48. Suzukawa, M., Ishikawa, T., Yashida, H. & Nakamura, H. (1995) Effect of in vitro supplementation with low-dose vitamin E on susceptibility of low-density lipoprotein and high-density lipoprotein to oxidative modification. J. Amer. Coll. Nutr. 14, 46-52.
49. Traber, M.G., Lane, J.C., Lagmay, N.R. & Kayden, H.J. (1992) Studies on the transfer of tocopherol between lipoproteins. Lipids 27, 657-663.